Correlation Between BioLineRx and Milestone Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both BioLineRx and Milestone Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioLineRx and Milestone Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioLineRx and Milestone Pharmaceuticals, you can compare the effects of market volatilities on BioLineRx and Milestone Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioLineRx with a short position of Milestone Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioLineRx and Milestone Pharmaceuticals.
Diversification Opportunities for BioLineRx and Milestone Pharmaceuticals
-0.52 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between BioLineRx and Milestone is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding BioLineRx and Milestone Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Milestone Pharmaceuticals and BioLineRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioLineRx are associated (or correlated) with Milestone Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Milestone Pharmaceuticals has no effect on the direction of BioLineRx i.e., BioLineRx and Milestone Pharmaceuticals go up and down completely randomly.
Pair Corralation between BioLineRx and Milestone Pharmaceuticals
Given the investment horizon of 90 days BioLineRx is expected to under-perform the Milestone Pharmaceuticals. In addition to that, BioLineRx is 2.48 times more volatile than Milestone Pharmaceuticals. It trades about -0.09 of its total potential returns per unit of risk. Milestone Pharmaceuticals is currently generating about 0.34 per unit of volatility. If you would invest 148.00 in Milestone Pharmaceuticals on September 4, 2024 and sell it today you would earn a total of 52.00 from holding Milestone Pharmaceuticals or generate 35.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 95.24% |
| Values | Daily Returns |
BioLineRx vs. Milestone Pharmaceuticals
Performance |
| Timeline |
| BioLineRx |
| Milestone Pharmaceuticals |
BioLineRx and Milestone Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BioLineRx and Milestone Pharmaceuticals
The main advantage of trading using opposite BioLineRx and Milestone Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioLineRx position performs unexpectedly, Milestone Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Milestone Pharmaceuticals will offset losses from the drop in Milestone Pharmaceuticals' long position.| BioLineRx vs. Ardelyx | BioLineRx vs. Lexicon Pharmaceuticals | BioLineRx vs. Seres Therapeutics | BioLineRx vs. Immunitybio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |